A huge low-grade fibromyxoid sarcoma of small bowel mesentery simulating hyper immune splenomegaly syndrome: a case report and review of literature.

Afr Health Sci

Department of Surgery, Faculty of Clinical Sciences, College of Health Science, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.

Published: September 2013

Introduction: Low-grade fibromyxoid sarcoma (LGFMS) is a rare non epithelial tumour. It usually arises from the smooth muscles of the extremities. It is, however, occasionally reported to arise from other regions of the body.

Case Report: We report the case of a 32 year old man who complained of a progressive abdominal swelling of 4 months duration. There was associated abdominal discomfort and weight loss. Abdominal examination revealed a non-tender intra abdominal mass filling the abdomen completely. Abdominal ultrasound suggested a massive splenomegaly. Abdomina Computerized Tomography (CT) scan was not done due to financial constraints. At laparotomy, a large, pearl-coloured mass was found within the mesentery of the proximal jejunum, with dilated, tortuous vessels. It was resected along with the overlying 60 cm of jejunum. It weighed 7.5 kg. Histology and immunohistochemistry confirmed the diagnosis of lowgrade fibromyxoid sarcoma. Post-operative period was uneventful and there were no features of recurrent after 2 year of follow up.

Conclusion: LGFMS may cause a diagnostic dilemma, especially in a third world setting where preoperative diagnosis is hampered by lack of facilities and poverty. A high index of suspicion is needed for preoperative diagnosis, which is necessary for proper planning of the operation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824459PMC
http://dx.doi.org/10.4314/ahs.v13i3.31DOI Listing

Publication Analysis

Top Keywords

fibromyxoid sarcoma
12
low-grade fibromyxoid
8
preoperative diagnosis
8
abdominal
5
huge low-grade
4
sarcoma small
4
small bowel
4
bowel mesentery
4
mesentery simulating
4
simulating hyper
4

Similar Publications

Sclerosing epithelioid fibrosarcoma (SEF) was originally described as a peculiar variant of fibrosarcoma in 1995. Subsequent studies showed that conventional SEF was associated with both immunohistochemical expression of MUC4 and EWSR1/FUS gene rearrangements with CREB3L1 as the predominant fusion partner. Since then, a distinct group of fibrous tumors characterized by YAP1::KMT2A and KMT2A::YAP1 gene rearrangements and SEF-like morphology has been described.

View Article and Find Full Text PDF

TFE3 rearrangements characterize histogenetically, topographically, and biologically diverse neoplasms. Besides being a universal defining feature in alveolar soft part sarcoma (ASPS) and clear cell stromal tumor of the lung, TFE3 fusions have been reported in subsets of renal cell carcinoma, perivascular epithelioid cell tumor (PEComa), epithelioid hemangioendothelioma and ossifying fibromyxoid tumors. TFE3-related neoplasms are rare in the head and neck and may pose diagnostic challenges.

View Article and Find Full Text PDF

The aim of the study was to report the outcome of primary localized low-grade fibromyxoid sarcoma (LGFMS), sclerosing epithelioid fibrosarcoma (SEF), and hybrid LGFMS/SEF (H-LGFMS/SEF). Patients with primary localized LGFMS, SEF, or H-LGFMS/SEF, surgically treated with curative intent from January 2000 to September 2022, were enrolled from 14 countries and 27 institutions. Pathologic inclusion criteria were predefined by expert pathologists.

View Article and Find Full Text PDF

TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.

Cancers (Basel)

October 2024

Department of Diagnostics and Public Health, Section of Pathology, University of Verona, 37134 Verona, Italy.

Article Synopsis
  • Identical translocations involving the TFE3 gene have been linked to various tumors, including specific renal and soft tissue cancers like alveolar soft part sarcoma and clear cell stromal tumor of the lung.
  • This review focuses on the clinicopathologic and molecular characteristics of TFE3-rearranged renal tumors, highlighting the complexity in their classification due to differing tumor types and features.
  • While the reason for the diverse morphologies associated with similar gene fusions remains unclear, the pathology community still supports maintaining distinct classifications for TFE3-rearranged renal cell carcinoma and TFE3-rearranged PEComa.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!